Treatment strategies for dosing the second generation antipsychotics. - Wikidata - awgldk - TriplyDB

Treatment strategies for dosing the second generation antipsychotics.

Treatment strategies for dosing the second generation antipsychotics.

http://www.wikidata.org/entity/Q37852818

about

Use of antipsychotics in the treatment of depressive disorders Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing.Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.Ziprasidone hydrocloride: what role in the management of schizophrenia?World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Conundrums in neurology: diagnosing serotonin syndrome - a meta-analysis of cases.Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.

P2860

Q26860391-E6430DC3-735E-4F1D-9F83-0D15BEBF6891 Q33747710-6DA81CC8-CECA-444B-9705-788ED1456BE3 Q34097289-021B3051-0A6F-441B-86D1-A66C79F22AF3 Q34357931-090B4DA0-6CFC-428C-B4DA-3CC0D030EFF3 Q34640811-95720EBC-D975-455F-A43B-2486D984482A Q36074323-CCCDCAEA-20BE-4C25-8632-98426232B7BA Q36325431-EA965248-3739-4FFA-AAB6-C7DF0C3C6889 Q38239613-643F4ED0-7108-4873-B193-19DF3F285890

P2860

Treatment strategies for dosing the second generation antipsychotics.

http://www.wikidata.org/entity/Q37852818

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treatment strategies for dosing the second generation antipsychotics.

@en

Treatment strategies for dosing the second generation antipsychotics.

@nl

type

label

Treatment strategies for dosing the second generation antipsychotics.

@en

Treatment strategies for dosing the second generation antipsychotics.

@nl

prefLabel

Treatment strategies for dosing the second generation antipsychotics.

@en

Treatment strategies for dosing the second generation antipsychotics.

@nl

P1433

Q37852818-669B4A56-9953-44CA-87D7-34AFABA5E3F6

P1476

Q37852818-372F2DAC-5F53-496F-8132-80C7DC1D364C

P2093

Q37852818-0F91D0F8-DAFF-4C90-9C84-B3E0FBAA5C79

Q37852818-B0A8F8C1-FD11-4DC7-9A99-08171CA45782

P2860

Q37852818-00202137-AF5C-4809-9CBB-FB2B108B727C

Q37852818-016AFE30-628F-485B-B463-E79F4D596A10

Q37852818-0A5E21C9-840F-4D2E-AA67-ED0CB5C952CB

Q37852818-0EAE9413-080D-4BDB-85C7-28607A7392A8

Q37852818-0F40F566-AA67-43BB-9D2D-CDF6D09355A3

Q37852818-0FA1ED6E-80C5-457B-9E5E-B252B75797AE

Q37852818-14F4A725-C26A-408D-8118-D59290F83549

Q37852818-1FCE43CE-321A-4F0C-BEDF-3219099B9F3A

Q37852818-21BAD901-CA46-4473-97AE-6647B344ECC5

Q37852818-241A4699-76EC-4D90-992E-C02B37912627

P304

Q37852818-BE141403-A31F-4A54-B4AB-9D67AE92CABE

P31

Q37852818-E3302660-D7FD-40D5-B35B-00AF89E0F007

P356

Q37852818-B6AF0F04-C517-42DE-9709-7FC9D36411B3

P433

Q37852818-11CCB626-0E58-43C1-A7E6-F96DEA852413

P478

Q37852818-1865338C-F243-4F89-BD2F-03031EDD966E

P577

Q37852818-8F9055B6-1AAA-449D-A506-AE939678FA8B

P5875

Q37852818-36AFD040-FB0E-444D-B0C9-8605705C19DE

P698

Q37852818-7EFE1769-082D-4427-A4D1-BF758B77BA3B

P932

Q37852818-FE9FE9F6-2E0A-4479-A701-4FD4185D02AA

P356

J.1755-5949.2011.00234.X

P1433

CNS Neuroscience & Therapeutics

P1476

Treatment strategies for dosing the second generation antipsychotics

@en

P2093

Stephen M Stahl

http://www.w3.org/2001/XMLSchema#string

Thomas L Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.

Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study.

The role of 5-HT2A receptors in antipsychotic activity.

Ziprasidone: a new atypical antipsychotic.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

P304

110-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5949.2011.00234.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50394117

http://www.w3.org/2001/XMLSchema#string

P698

21401911

http://www.w3.org/2001/XMLSchema#string

P932

6493839

http://www.w3.org/2001/XMLSchema#string